LIS Technologies Inc. Announces Fourth Consecutive Oversubscribed Funding Round of $17 Million, Totaling $64 Million to Revitalize the Only U.S.-Origin, Patented Laser Uranium Enrichment Technology to Support the Domestic Nuclear Fuel Cycle
Oak Ridge, Tennessee--(Newsfile Corp. - January 13, 2026) - LIS Technologies Inc. ("LIST" or "the Company"), a proprietary developer of advanced laser technology and the only USA-origin and patented laser uranium enrichment company, today announced that it has closed its 240% oversubscribed $17 Million funding round. The round attracted participation from a single large, accredited investor that accounted for the majority of initial raise, along with returning advanced nuclear technolo
Technology, Mining and Metals, Energy, Health
2026-01-13 8:59 AM EST | LIS Technologies Inc.
Cardiol Therapeutics Achieves Key 50% Patient Enrollment Milestone in Pivotal Phase III MAVERIC Trial in Recurrent Pericarditis
Toronto, Ontario--(Newsfile Corp. - January 13, 2026) - Cardiol Therapeutics Inc. (NASDAQ:
Biotechnology, Cannabis, Health, Cannabis Manufacturer
2026-01-13 7:27 AM EST | Cardiol Therapeutics Inc.
TempraMed Closes C$2.5 Million Fully Subscribed Private Placement
Vancouver, British Columbia--(Newsfile Corp. - January 12, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE: 9DY) ("TempraMed" or the "Company"), a medical-technology innovator transforming how temperature-sensitive medications are stored and managed, is pleased to announce the fully subscribed closing of its previously announced non-brokered private placement (the "Offering"), issuing 3,322,153 units (each, a "Unit") at a price of $0.76 p
Technology, Biotechnology, Pharmaceuticals, Health
2026-01-12 5:30 PM EST | TempraMed Technologies Ltd
Predictmedix AI Inc. Announces Proposed Name Change to QScreen AI Inc., Pioneering the Fusion of Quantum Computing and AI to Transform Healthcare
Toronto, Ontario--(Newsfile Corp. - January 12, 2026) - Predictmedix AI Inc. (CSE: PMED) (OTC Pink: PMEDF) (FSE: 3QP0) ("Predictmedix" or the "Company"), excited to announce its proposed name change to QScreen AI Inc., with a new ticker symbol QAI, subject to regulatory approval. This strategic rebranding underscores the Company's evolution into a premier healthcare innovator, uniquely positioned at the intersection of artificial intelligence, quantum-inspired computing, and data-driven healt
2026-01-12 7:11 AM EST | Predictmedix AI Inc.
CBIH Puts CMS at the Center of the Board: Formal Coordination with Dr. Mehmet Oz's Team and an "Evidence Sprint 2026" Focused on Grants, Research and Clinical Evidence
Houston, Texas--(Newsfile Corp. - January 12, 2026) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public company trading on the OTC Markets under the ticker symbol CBIH, announced today the launch of its Evidence Sprint 2026, an intensive execution phase designed to turn cannabinoid science into usable medical evidence: protocols, operational collaboration, and projects ready for competitive funding. CBIH confirms receipt of a communication from the Centers for Med
Biotechnology, Pharmaceuticals, Cannabis, Health
2026-01-12 7:00 AM EST | Cannabis Bioscience International Holdings
Cosmo Enters Scale Up Phase with 104M Revenue, 128M Cash, and Breakout AI and Dermatology Platforms
Ad hoc announcement pursuant to Art. 53 LR 2025 marks a key execution year in Cosmo’s Vision 2030, strengthening the Company’s foundations for scalable, innovation-driven growth across AI-enabled MedTech and pharma. Financial Highlights: High quality growth: €104 million revenue at guidance midpoint (€102 to €107 million) with recurring revenu
Healthcare and Hospitals, Health
2026-01-12 1:02 AM EST | Cosmo Pharmaceuticals N.V.
ADIA Nutrition Appoints Dawn Bell as Chief Revenue Officer to Accelerate Growth and Drive Success Across Physician Network
Winter Park, Florida--(Newsfile Corp. - January 8, 2026) - ADIA Nutrition, Inc. (OTCQB: ADIA), a rapidly growing leader in regenerative medicine, today announced the appointment of Dawn Bell as Chief Revenue Officer (CRO) through its subsidiary, ADIA Labs. Ms. Bell brings more than 15 years of proven expertise as a sales strategist in the medical device and pharmaceutical industries, with a strong history of driving growth and building successful partnerships.
Healthcare and Hospitals, Health
2026-01-08 8:30 AM EST | Adia Nutrition Inc.
Akanda Corp. Announces Reverse Stock Split
Toronto, Ontario--(Newsfile Corp. - January 8, 2026) - Akanda Corp. (NASDAQ: AKAN) (the "Company" or "Akanda"), today announced that it expects to implement a 1-for-5 reverse stock split of the Company's common shares effective January 12, 2026. The reverse stock split was previously approved by the Company's shareholders on November 28, 2025 and Board of Directors on December 23, 2025 and will begin trading on an adjusted basis giving effect to the reverse stock split at the opening of marke
Cannabis, Health, Cannabis Cultivator, Cannabis Manufacturer
2026-01-08 8:30 AM EST | Akanda Corp
BioVaxys Announces Phase 1 Clinical Study Results Advancing DPX(TM)-Formulated Products in Patients with Non-Muscle Invasive Bladder Cancer
Vancouver, British Columbia--(Newsfile Corp. - January 8, 2026) - BioVaxys Technology Corp. (CSE: BIOV) (FSE: 5LB0) (OTCQB: BVAXF) ("BioVaxys" or the "Company"), a clinical stage biotechnology company focused on developing advanced treatments in oncology, infectious disease, allergy, and other immune diseases based on its DPX™ antigen delivery and immune-educating technology platform, is pleased to announce highly promising results from a two-arm phase 1 clinical study of the safety and
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2026-01-08 8:00 AM EST | BioVaxys Technology Corp.
MyndTec Inc. Completes Additional Tranche of Non-Brokered Private Placement
Mississauga, Ontario--(Newsfile Corp. - January 7, 2026) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"), a neurological treatment and rehabilitation medical technology company, is pleased to announce that it has closed an additional tranche of its non-brokered private placement previously announced on January 30, 2025 (the "Offering"). The additional tranche of the private placement, the tenth of the Offering, consists of 618,118 Units of the Company (t
Technology, Healthcare and Hospitals, Health
2026-01-07 6:00 PM EST | MyndTec Inc.
Apollo Biowellness, Inc., Announces Expiration of Letter of Intent, Negotiations Continue
North Bergen, New Jersey--(Newsfile Corp. - January 7, 2026) - Apollo Biowellness, Inc. (OTCID: KOAN) (the "Company"), announces that the Letter of Intent between the Company and Revive Regenerative, Inc., dated September 12, 2025, (the "LOI") has expired and it no longer in effect.
Household / Consumer / Cosmetics, Health
2026-01-07 9:30 AM EST | Apollo Biowellness, Inc.
Broadreach Medical Resources (BMR) Announces Rebrand to HarmonyRx, Reflecting a New Era of Clinical-First Pharmacy Benefit Management
New York, New York--(Newsfile Corp. - January 7, 2026) - Broadreach Medical Resources (BMR), a leader in pharmacy benefit consulting and strategic clinical management, announces our rebrand to HarmonyRx-a name that represents the company's evolution, mission and commitment to aligning clinical excellence with financial value. The new brand identity reflects HarmonyRx's philosophy: that the most effective pharmacy strategies bring together evidence, clinical insight and cost stewardship
2026-01-07 8:08 AM EST | HarmonyRx
Glow Lifetech Expands into Medical Cannabis Channel with National Launch on Mendo Medical
Toronto, Ontario--(Newsfile Corp. - January 7, 2026) - Glow Lifetech Corp. (CSE: GLOW) (OTCID: GLWLF) (FSE: 9DO) ("Glow" or the "Company") is pleased to announce the launch of its MOD™ and .decimal™ product portfolio on the Mendo Medical Cannabis platform ("Mendo"), representing Glow's first formal entry into the Canadian medical cannabis channel and extending access to its products for registered medical patients nationwide. This launch represents an important
2026-01-07 7:30 AM EST | Glow Lifetech Corp.
BioHarvest Sciences Issues Year End Shareholder Letter
British Columbia and Rehovot, Israel--(Newsfile Corp. - January 7, 2026) - BioHarvest Sciences Inc., (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or "the Company"), a company pioneering its patented Botanical Synthesis technology process, today issued a letter to shareholder partners from Chief Executive Officer, Ilan Sobel. Dear Fellow Shareholders, 2025 marked an important milestone for BioHarvest Scie
Biotechnology, Pharmaceuticals, Health
2026-01-07 7:30 AM EST | BioHarvest Sciences Inc.
TempraMed Receives First Commercial Order from Israel Distributor and Completes Initial Shipment Enabling Entry into National Pharmacy Network
Vancouver, British Columbia--(Newsfile Corp. - January 6, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE: 9DY) ("TempraMed" or the "Company"), a medical-technology innovator transforming how temperature-sensitive medications are stored and managed, is pleased to announce its first commercial order in Israel and the successful delivery of an initial shipment to the warehouse of Guri A.A.O. ("Guri"), a leading Israeli medical distribution company.
Technology, Biotechnology, Pharmaceuticals, Health
2026-01-06 5:00 PM EST | TempraMed Technologies Ltd
PhantomOmics Announces Clinical Collaboration with Banff Sport Medicine to Advance Non-Invasive Health Scanning Protocols
Calgary, Alberta--(Newsfile Corp. - January 6, 2026) - PhantomOmics Inc., a Calgary-based health technology company developing non-invasive, AI-powered health scanning systems, today announced a new clinical collaboration with Banff Sport Medicine, one of Canada's leading orthopaedic and sport medicine clinics.
Technology, Healthcare and Hospitals, Sensor, Health
2026-01-06 4:27 PM EST | PhantomOmics Inc.
St. Baldrick's Foundation Announces 2026 Ambassadors
Los Angeles, California--(Newsfile Corp. - January 6, 2026) - The St. Baldrick's Foundation, the largest charity funder of childhood cancer research grants in the U.S., is proud to announce its 2026 Ambassadors. Along with their families, these ambassadors will share their personal journeys and experiences with childhood cancer to raise awareness and inspire action to
2026-01-06 12:00 PM EST | St. Baldrick's Foundation
BetterLife Pharma to Participate in YAFO Capital Access Asia Partnering Forum During JPM Week in San Francisco
Vancouver, British Columbia--(Newsfile Corp. - January 6, 2026) - BetterLife Pharma Inc. (CSE: BETR) (OTCQB: BETRF) (FSE: NPAU) ("BetterLife" or the "Company"), an emerging biopharmaceutical company focused on development of BETR-001, its proprietary non-hallucinogenic derivative of lysergic acid diethylamide ("LSD") for the treatment of neurological disorders, today announced that it will be participating in the YAFO Capital Access Asia 2025 Partnering Forum, held in San Franc
2026-01-06 8:00 AM EST | BetterLife Pharma Inc.
Aleen Inc. Announces Upcoming Enhancements to the Personal Account
Toronto, Ontario--(Newsfile Corp. - January 6, 2026) - Aleen Inc. (CSE: ALEN.U), a digital wellness company, announces that starting in early 2026, it will begin rolling out new features and improvements within the Personal Account, its user-facing tool for managing wellness information. Planned enhancements include improved data organization, interactive visualizations, and a refined user experience, helping users gain clearer insights into personal wellness patterns wit
2026-01-06 8:00 AM EST | Aleen Inc.
Beckett's Kicks Off Multi-Channel Dry January Campaign Across Retail, Subscription Services, and Influencer Partnerships
Ontario and Los Angeles, California--(Newsfile Corp. - January 6, 2026) - Beckett's Inc. (CSE: BKTS) (OTCQB: BKTSF), a fast-growing non-alcoholic beverage brand has launched a national Dry January initiative spanning major retail, subscription, and influencer channels. The month-long campaign includes featured promotions at Total Wine & More, Walmart.com, Amazon.com, national non-alcoholic subscription service Raising the Bar, Los Angeles bottle shop Burden of Proof, along w
Food / Beverages, Cannabis, Health
2026-01-06 7:30 AM EST | Becketts Inc.